Form 4 for TDOC Teladoc Health, Inc.
Accepted 2021-11-04 00:00:00 ET · period of report 2021-11-03 · accession 0001179110-21-009878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-04 | 2021-11-03 | TDOC | Verstraete Stephany | CMO | S - Sale+OE | $154.25 | -1,000 | 22.3K | -4% | -$154.2K |
| D | 2021-11-04 | 2021-11-03 | TDOC | Verstraete Stephany | CMO | M - OptEx | $38.55 | +1,000 | 23.3K | +4% | +$38.5K |
| D | 2021-11-04 | 2021-11-03 | TDOC | Verstraete Stephany | CMO | M - OptEx | $0.00 | -1,000 | 45.3K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-03 | S | D | 1,000 | $154.25 | 22,278 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-03 | M | A | 1,000 | $38.55 | 23,278 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2021-11-03 | M | D | 1,000 | $0.00 | 45,331 | D | $38.55 · — to 2028-03-01 | 1,000 Common Stock | (F2) The option vested as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 substantially equal monthly installments thereafter. |